Monday, November 25, 2024
HomeTagsTCMC

TCMC

Soleo Health Prepared to Meet Increased Demand of FDA-Approved LEQEMBI™ (lecanemab-irmb) to Treat Alzheimer’s Disease

Company Provides Alzheimer’s Disease Patients Greater Access to Care through Administration of LEQEMBI In-home or On-site at its Infusion Centers Soleo Health, an innovative leader and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics